Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016 (2016), Article ID 8025271, 5 pages
http://dx.doi.org/10.1155/2016/8025271
Research Article

Diagnostic Utility of Neuregulin for Acute Coronary Syndrome

1Department of Emergency Medicine, Vanderbilt University School of Medicine, 703 Oxford House, 1313 21st Avenue S., Nashville, TN 37232, USA
2Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, TN 37203, USA
3Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

Received 4 December 2015; Accepted 17 February 2016

Academic Editor: Mariann Harangi

Copyright © 2016 Maame Yaa A. B. Yiadom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, B. R. Chaitman, and H. D. White, “Third universal definition of myocardial infarction,” Journal of the American College of Cardiology, vol. 60, no. 16, pp. 1581–1598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Morrow, C. P. Cannon, R. L. Jesse et al., “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes,” Clinical Chemistry, vol. 53, no. 4, pp. 552–574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. H. B. Wu, A. S. Jaffe, F. S. Apple et al., “National academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure,” Clinical Chemistry, vol. 53, no. 12, pp. 2086–2096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kennon, A. D. Timmis, R. Whitbourn, and C. Knight, “C reactive protein for risk stratification in acute coronary syndromes? Verdict: unproven,” Heart, vol. 89, no. 11, pp. 1288–1290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. Emerging Risk Factor Collaboration, S. Kaptoge, E. DiAngelantonio, G. Lowe et al., “C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis,” The Lancet, vol. 375, no. 9709, pp. 132–140, 2010. View at Publisher · View at Google Scholar
  6. M. K. Sinha, D. Roy, D. C. Gaze, P. O. Collinson, and J.-C. Kaski, “Role of ‘ischemia modified albumin’, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes,” Emergency Medicine Journal, vol. 21, no. 1, pp. 29–34, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Keating, J. R. Benger, R. Beetham et al., “The PRIMA study: presentation ischaemia-modified albumin in the emergency department,” Emergency Medicine Journal, vol. 23, no. 10, pp. 764–768, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. P. Goetze, C. Christoffersen, M. Perko et al., “Increased cardiac BNP expression associated with myocardial ischemia.,” The FASEB Journal, vol. 17, no. 9, pp. 1105–1107, 2003. View at Google Scholar · View at Scopus
  9. T. Omland, A. Persson, L. Ng et al., “N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes,” Circulation, vol. 106, no. 23, pp. 2913–2918, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Burden and Y. Yarden, “Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis,” Neuron, vol. 18, no. 6, pp. 847–855, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Kuramochi, G. M. Cote, X. Guo et al., “Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1β/erbB4 signaling,” The Journal of Biological Chemistry, vol. 279, no. 49, pp. 51141–51147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Ky, S. E. Kimmel, R. N. Safa et al., “Neuregulin-1β is associated with disease severity and adverse outcomes in chronic heart failure,” Circulation, vol. 120, no. 4, pp. 310–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. A. Geisberg, G. Wang, R. N. Safa et al., “Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia,” Coronary Artery Disease, vol. 22, no. 8, pp. 577–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. E. A. Amsterdam, J. D. Kirk, D. A. Bluemke et al., “AHA scientific statement: testing of low-risk patients presenting to the emergency department with chest pain,” Chest, vol. 122, pp. 1756–1776, 2010. View at Publisher · View at Google Scholar
  15. F. S. Apple and D. A. Morrow, “Delta cardiac troponin values in practice: are we ready to move absolutely forward to clinical routine?” Clinical Chemistry, vol. 58, no. 1, pp. 8–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. L. Mills, A. M. D. Churchhouse, K. K. Lee et al., “Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome,” The Journal of the American Medical Association, vol. 305, no. 12, pp. 1210–1216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Morrow, C. P. Cannon, R. L. Jesse et al., “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes,” Circulation, vol. 115, no. 13, pp. e356–e375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. B. Storrow, T. A. Lardaro, P. T. Alexander, and F. S. Apple, “How low can we go? the high-sensitivity cardiac troponin debate,” Annals of Emergency Medicine, vol. 62, no. 6, pp. 580–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. E. O. McFalls, G. Larsen, G. R. Johnson et al., “Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level,” American Journal of Medicine, vol. 124, no. 7, pp. 630–635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. Morrow and E. M. Antman, “Evaluation of high-sensitivity assays for cardiac troponin,” Clinical Chemistry, vol. 55, no. 1, pp. 5–8, 2009. View at Publisher · View at Google Scholar · View at Scopus